CA1266675C - - Google Patents

Info

Publication number
CA1266675C
CA1266675C CA 478535 CA478535A CA1266675C CA 1266675 C CA1266675 C CA 1266675C CA 478535 CA478535 CA 478535 CA 478535 A CA478535 A CA 478535A CA 1266675 C CA1266675 C CA 1266675C
Authority
CA
Canada
Prior art keywords
alkyl
hydrogen
intermediates
cycloalkyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA 478535
Other languages
English (en)
Other versions
CA1266482A1 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to CA000556569A priority Critical patent/CA1266675A/en
Publication of CA1266482A1 publication Critical patent/CA1266482A1/en
Application granted granted Critical
Publication of CA1266675C publication Critical patent/CA1266675C/xx
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA000478535A 1984-05-24 1985-04-09 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines Granted CA1266482A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000556569A CA1266675A (en) 1984-05-24 1988-01-14 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61383984A 1984-05-24 1984-05-24
US613,839 1984-05-24

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA000556569A Division CA1266675A (en) 1984-05-24 1988-01-14 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines

Publications (2)

Publication Number Publication Date
CA1266482A1 CA1266482A1 (en) 1990-03-06
CA1266675C true CA1266675C (es) 1990-03-13

Family

ID=24458880

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000478535A Granted CA1266482A1 (en) 1984-05-24 1985-04-09 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines

Country Status (11)

Country Link
EP (1) EP0162695B1 (es)
JP (1) JPS60258162A (es)
AT (1) ATE49592T1 (es)
AU (1) AU581000B2 (es)
CA (1) CA1266482A1 (es)
DE (1) DE3575420D1 (es)
DK (1) DK222385A (es)
ES (2) ES8700233A1 (es)
GR (1) GR851263B (es)
PT (1) PT80524B (es)
ZA (1) ZA853913B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346573A1 (de) * 1983-12-23 1985-07-04 Troponwerke GmbH & Co KG, 5000 Köln 1,3,4,5-tetrahydrobenz(c,d)indole, ein verfahren zu ihrer herstellung und ihre verwendung
US4983622A (en) * 1984-02-06 1991-01-08 Eli Lilly And Company 6-substituted-4-dialkylaminotetrahydrobenz(c,d)indoles
US5026869A (en) * 1984-02-06 1991-06-25 Eli Lilly And Company 6-substituted-4-dialkylaminotetrahydrobenz(c,d)indoles
IL74222A (en) * 1984-02-06 1988-07-31 Lilly Co Eli 6-substituted-4-dialkylamino tetrahydrobenz(c,d)indoles,their preparation and pharmaceutical compositions comprising them
DE3718892A1 (de) * 1987-06-05 1988-12-22 Bayer Ag Polyhydrobenz(c,d)indol-sulfonamide
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
US5302612A (en) * 1990-02-26 1994-04-12 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles
US5229410A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
US5244912A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof
US5654324A (en) * 1991-03-28 1997-08-05 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[cd]indoles
US5244911A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd)indoles and pharmaceutical use thereof
US5347013A (en) * 1991-03-28 1994-09-13 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
US5364856A (en) * 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
ZA943862B (en) * 1993-06-10 1995-12-04 Lilly Co Eli Method of preventing emesis and treating sexual dysfunction using tetrahydrobenz[cd] indole-6-carboxamides
FR2732964B1 (fr) * 1995-04-14 1997-05-16 Adir Nouveaux amides tricycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194811A (en) * 1963-09-05 1965-07-13 Merck & Co Inc Aroyl-benzindolyl acids
CH517732A (de) * 1969-10-24 1972-01-15 Sandoz Ag Verfahren zur Herstellung neuer Guanidin- Verbindungen
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
US4282240A (en) * 1979-11-23 1981-08-04 Merck & Co., Inc. Amino substituted tetrahydrobenzindoles
DE3346573A1 (de) * 1983-12-23 1985-07-04 Troponwerke GmbH & Co KG, 5000 Köln 1,3,4,5-tetrahydrobenz(c,d)indole, ein verfahren zu ihrer herstellung und ihre verwendung
IL74222A (en) * 1984-02-06 1988-07-31 Lilly Co Eli 6-substituted-4-dialkylamino tetrahydrobenz(c,d)indoles,their preparation and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
DE3575420D1 (de) 1990-02-22
ATE49592T1 (de) 1990-02-15
ES543421A0 (es) 1986-09-16
GR851263B (es) 1985-11-25
AU4279685A (en) 1985-11-28
ES8700233A1 (es) 1986-09-16
PT80524B (en) 1987-04-06
AU581000B2 (en) 1989-02-09
JPS60258162A (ja) 1985-12-20
PT80524A (en) 1985-06-01
EP0162695B1 (en) 1990-01-17
CA1266482A1 (en) 1990-03-06
EP0162695A1 (en) 1985-11-27
ES8706117A1 (es) 1987-06-01
DK222385D0 (da) 1985-05-20
ZA853913B (en) 1986-01-29
DK222385A (da) 1985-11-25
ES551944A0 (es) 1987-06-01

Similar Documents

Publication Publication Date Title
CA1266675C (es)
ES485621A1 (es) Un procedimiento para la preparacion de derivados de diben- zopirano
GR3004273T3 (es)
EP0222693A3 (en) 3-oxadiazolyl and 3-carboxylic-acid beta-carboline derivatives, their preparation and their use as medicaments
DE3362504D1 (en) 1-carboxyalkanoylindoline-2-carboxylic-acid esters, their preparation, pharmaceutical compositions containing them, and their therapeutic use
FI862420A (fi) Pyrrolidonderivat.
SE8303913L (sv) Heterocykliska foreningar
ZA872683B (en) 1,5-benzothiazepine derivatives,their preparation and compositions containing them
IL70341A0 (en) Pyrimidone derivatives,processes for their preparation,pharmaceutical compositions containing them and their use as histamine antagonists
IL79785A0 (en) Tetraoxo compounds,their preparation and pharmaceutical compositions containing them
ATE38029T1 (de) Benz-trisubstituierte 2-aminotetraline.
GR3007498T3 (es)
ES2044883T3 (es) Procedimiento para preparar quinoxalinas sustituidas.
ES2001701A6 (es) Un metodo para preparar compuesto de benzoilurea
IL76155A0 (en) Benzoylurea derivatives,their preparation and pesticidal compositions containing them
ATE74604T1 (de) Substituierte pyrimidochinoxaline.

Legal Events

Date Code Title Description
MKLA Lapsed